Why Should I attend?
As the ONE and ONLY event in South East Asia region to cover the end-to-end supply chain, you’ll be able to meet suppliers as well as exhibitors across sectors: from CRO and Clinical Trials to Manufacturing, Packaging, and Finished Products.
Furthermore, with our killer SMART event program that brings together all the interactive features of both an online and onsite experience, we extend your opportunities to network, source, and learn what you need to help your business grow!
Why Thailand Pharmaceutical Industry ?
Thailand’s pharma industry is the 2nd largest in SEA market Gathering over 300+ exhibitors and 8,000 pharma professionals from Aasen and around the world, CPHI SEA is the ideal platform to meet the excellence pharma companies to tap into this attractive market and source the latest technologies and innovative products.
Strong intellectual property environment.
Strengthening clinical research landscape.
Strong patented drugs market due to the region's wealth and Thailand's preference for branded drugs valued at 1.8 hundred thousand million.
Well-established pharmaceutical manufacturing capacity, hosting some of the world's leading manufacturers, with high rates of R&D.
A well-developed healthcare system with high government contribution with a new S-curve campaign.
High demand for pharmaceuticals driven by an ageing population.
Seize Your Golden Opportunities
Pharmaceutical supply chains play an important role to connect all pharma stakeholders across the healthcare value chain in Thailand and distribution capacities are expanding to meet the needs of the market.
Thailand is well-positioned to increase the development of its pharmaceutical industry, with the current human resource pool, technological know-how, and collaborative efforts during the crisis, among other factors. However, the country has not yet moved up the value chain to more in-depth research or more sophisticated expertise.
Thailand is positioned for success in this arena become to reginal leading, with the potential to leap forward from simply being a supplier to the industry. With an educated workforce, teaching institutions, as well as geographic location.
An ageing population and a rising number of chronic and long-term diseases create opportunities for makers of innovative products.
